BRIEF-Oxford Biomedica says GSK options rare disease candidates
Dec 18 (Reuters) - Oxford BioMedica PLC : * Announces option agreement with GlaxoSmithkline * Grants GSK an option for the development of up to six candidates targeting
rare orphan diseases * Source text
- Tesla says in talks with BMW over car batteries, parts
- Exclusive: China ready to cut rates again on fears of deflation - sources
- Actor Dwight Henry eyed in New Orleans killing after arrest for theft
- China building South China Sea island big enough for airstrip: report
- Obama to Republican critics on immigration: 'Pass a bill'